Chittaranjan Andrade, MD
Department of Psychiatry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India, Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India ([email protected])
Clinical and Practical Psychopharmacology
Insights on Use of Ketamine From RCTs of Ketamine vs Electroconvulsive Therapy in Severe Depression
March 28, 2022
ECT outperformed ketamine in recent randomized controlled trials. These studies also, however, shed light on ketamine’s potential as a viable alternative to ECT in some severely depressed patients.
Clinical and Practical Psychopharmacology
Gestational Exposure to Antidepressants and Neurodevelopment
January 25, 2022
A large new study of youth aged 9–15 years with a history of gestational exposure to antidepressants revealed slightly poorer performance in mathematics, but not in language. Dr Andrade...
Clinical and Practical Psychopharmacology
Limitations of the Odds Ratio in a Case-Control Study of Breast Cancer and Exposure to Antipsychotics
November 23, 2021
Dr Andrade considers the limitations of the odds ratio in a study of prolactin-raising vs prolactin-sparing antipsychotics and breast cancer risk, with the aim of helping readers understand how...
Clinical and Practical Psychopharmacology
Gestational and Neurodevelopmental Outcomes Associated With Exposure to Antipsychotics
October 12, 2021
This article discusses a recent large cohort study of neurodevelopmental outcomes (ADHD, autism) after gestational exposure of antipsychotics—including the limitations of the study.
